MAPT and tauopathy: Recent studies have shown degradation of tau by proteasome (Boland et al., 2018; Opoku‐Nsiah & Gestwicki, 2018), while our current study provides a new mechanism of PA28γ‐20S proteasome/PKAR2α in tauopathy.